FR2983077B1 - SYRINGE - Google Patents

SYRINGE Download PDF

Info

Publication number
FR2983077B1
FR2983077B1 FR1350671A FR1350671A FR2983077B1 FR 2983077 B1 FR2983077 B1 FR 2983077B1 FR 1350671 A FR1350671 A FR 1350671A FR 1350671 A FR1350671 A FR 1350671A FR 2983077 B1 FR2983077 B1 FR 2983077B1
Authority
FR
France
Prior art keywords
syringe
relates
present
small volume
ophthalmic injections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1350671A
Other languages
French (fr)
Other versions
FR2983077A1 (en
Inventor
Juergen Sigg
Christophe Royer
Andrew Mark Bryant
Heinrich Martin Buettgen
Marie Picci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48051683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2983077(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE202012011016U external-priority patent/DE202012011016U1/en
Priority claimed from AU2013100071A external-priority patent/AU2013100071C4/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of FR2983077A1 publication Critical patent/FR2983077A1/en
Application granted granted Critical
Publication of FR2983077B1 publication Critical patent/FR2983077B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une seringue, en particulier une seringue de petit volume telle qu'une seringue appropriée pour les injections ophtalmiques.The present invention relates to a syringe, in particular a small volume syringe such as a syringe suitable for ophthalmic injections.

FR1350671A 2012-07-03 2013-01-25 SYRINGE Active FR2983077B1 (en)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
EP12174860.2 2012-07-03
EP12174860 2012-07-03
EP12189649.2 2012-10-23
EP12189649 2012-10-23
DE202012011016U DE202012011016U1 (en) 2012-07-03 2012-11-16 Aflibercept syringe
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
DE202012011260U DE202012011260U1 (en) 2012-07-03 2012-11-23 Ranibizumab Injection
DE202012011259U DE202012011259U1 (en) 2012-07-03 2012-11-23 Bevacizumab syringe
EP12195360.8 2012-12-03
EP12195360 2012-12-03
DE201320000688 DE202013000688U1 (en) 2012-07-03 2013-01-23 Glass syringe
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device

Publications (2)

Publication Number Publication Date
FR2983077A1 FR2983077A1 (en) 2013-05-31
FR2983077B1 true FR2983077B1 (en) 2018-09-14

Family

ID=48051683

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1350671A Active FR2983077B1 (en) 2012-07-03 2013-01-25 SYRINGE

Country Status (40)

Country Link
US (1) US9220631B2 (en)
EP (5) EP3656373B1 (en)
JP (2) JP5744927B2 (en)
KR (7) KR102443606B1 (en)
CN (4) CN104427972A (en)
AR (1) AR090059A1 (en)
AU (1) AU2013201624A1 (en)
BR (2) BR122020020290B1 (en)
CA (1) CA2803566A1 (en)
CH (1) CH706741B1 (en)
CL (1) CL2014003619A1 (en)
CO (1) CO7151483A2 (en)
CY (2) CY1121497T1 (en)
DE (1) DE202013000688U1 (en)
DK (4) DK3381444T3 (en)
EA (1) EA031583B1 (en)
EC (1) ECSP15004005A (en)
ES (4) ES2912848T3 (en)
FR (1) FR2983077B1 (en)
GT (1) GT201400300A (en)
HK (1) HK1188404A1 (en)
HR (4) HRP20220083T1 (en)
HU (3) HUE055227T2 (en)
IL (2) IL236296B (en)
JO (2) JOP20200175A1 (en)
LT (4) LT3656373T (en)
MA (1) MA37740B2 (en)
MX (1) MX358323B (en)
MY (1) MY164536A (en)
NZ (1) NZ702980A (en)
PE (1) PE20150196A1 (en)
PH (1) PH12014502785A1 (en)
PL (4) PL3381444T3 (en)
PT (1) PT2869813T (en)
SG (1) SG11201408261UA (en)
SI (4) SI3685826T1 (en)
TN (1) TN2014000517A1 (en)
TW (1) TWI632920B (en)
WO (1) WO2014005728A1 (en)
ZA (1) ZA201409411B (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3195874A1 (en) 2005-03-25 2017-07-26 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations
EP2364691B1 (en) 2006-06-16 2013-04-24 Regeneron Pharmaceuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
EP2776603B1 (en) 2011-11-11 2019-03-06 SiO2 Medical Products, Inc. PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
US9554968B2 (en) 2013-03-11 2017-01-31 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging
HRP20211572T1 (en) 2012-06-01 2022-02-04 Novartis Ag Syringe
JOP20200175A1 (en) 2012-07-03 2017-06-16 Novartis Ag Syringe
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
EP2968073B1 (en) * 2013-03-13 2017-08-16 Rush University Medical Center Delivery device for oropharyngeal administration of mother's colostrum and milk
US20140350518A1 (en) * 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
EP3693493A1 (en) 2014-03-28 2020-08-12 SiO2 Medical Products, Inc. Antistatic coatings for plastic vessels
US20170232199A1 (en) * 2014-05-12 2017-08-17 Formycon Ag Pre-Filled Plastic Syringe Containing a VEGF Antagonist
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
TWI705827B (en) 2014-11-07 2020-10-01 瑞士商諾華公司 Methods for treating ocular diseases
EP3058974A1 (en) 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Injection device with supplementary device
WO2016150900A2 (en) 2015-03-23 2016-09-29 Sanofi-Aventis Deutschland Gmbh Injection device
MA41906A (en) 2015-04-10 2018-02-13 Dompe Farm Spa EYE DROP DISTRIBUTION DEVICE
EP3377100A1 (en) * 2015-11-18 2018-09-26 Formycon AG Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist
JP2019501687A (en) * 2015-11-18 2019-01-24 フォーマイコン アーゲーＦｏｒｍｙｃｏｎ Ａｇ Prefilled plastic syringe containing VEGF antagonist
EP3377040B8 (en) 2015-11-18 2024-06-05 SiO2 Medical Products, Inc. Pharmaceutical package for ophthalmic formulations
AU2016364817B2 (en) 2015-12-03 2020-05-07 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
AU2016381964B2 (en) 2015-12-30 2024-02-15 Kodiak Sciences Inc. Antibodies and conjugates thereof
RU2738018C2 (en) * 2016-04-15 2020-12-07 Сантен Фармасьютикал Ко., Лтд. Accurate, precision microliter dispensing syringe
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
CN109312182B (en) 2016-06-17 2021-12-24 花王株式会社 Water-based ink
TWI737742B (en) * 2016-06-22 2021-09-01 德商梅茲製藥有限兩合公司 Botulinum toxin prefilled syringe system, kit having the same and use thereof
ITUA20162072A1 (en) * 2016-06-30 2017-12-30 Platinum Corp Srl Volume controlled dropper
EP3502050B1 (en) 2016-08-22 2022-12-21 Fuji Corporation Method for producing aqueous hydrogen peroxide
US10537683B2 (en) 2016-11-03 2020-01-21 Johnson & Johnson Surgical Vision, Inc. Syringe finger grip
ES2960921T3 (en) 2017-03-27 2024-03-07 Regeneron Pharma Sterilization procedure
WO2018191412A1 (en) 2017-04-12 2018-10-18 Urigen Pharmaceuticals, Inc. Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
EP3618893B1 (en) 2017-05-05 2023-03-29 Alcon Inc. A syringe comprising a collapsible plunger
EP3630062A2 (en) 2017-05-24 2020-04-08 SiO2 Medical Products, Inc. Sterilizable pharmaceutical package for ophthalmic formulations
WO2018217995A1 (en) 2017-05-24 2018-11-29 Formycon Ag Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
WO2018232408A1 (en) 2017-06-16 2018-12-20 Credence Medsystems, Inc. System and method for safety syringe
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
FR3072297B1 (en) * 2017-10-17 2023-05-12 Edix Sa MANUAL INJECTION DEVICE
SG11202005132QA (en) 2017-12-13 2020-06-29 Regeneron Pharma Devices and methods for precision dose delivery
EP3746156B1 (en) 2018-02-02 2023-12-06 F. Hoffmann-La Roche AG Prefilled syringe and method of sterilizing a prefilled syringe
CN112203679A (en) 2018-03-02 2021-01-08 科达制药股份有限公司 IL-6 antibodies and fusion constructs and conjugates thereof
JP2021520868A (en) * 2018-04-09 2021-08-26 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド Telescopic plunger assembly
WO2019209260A1 (en) * 2018-04-24 2019-10-31 W. L. Gore & Associates, Inc. Medical delivery devices with inhibited oxygen permeation
US11519020B2 (en) 2018-05-25 2022-12-06 Regeneron Pharmaceuticals, Inc. Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
US20210260300A1 (en) * 2018-06-01 2021-08-26 Sun Pharma Advanced Research Company Limited An injection device
CN113226228A (en) * 2018-10-26 2021-08-06 新加坡保健服务集团有限公司 Device and method for ophthalmic extraction and injection
CA3119277A1 (en) 2018-11-13 2020-05-22 Credence Medsystems, Inc. System and method for microdose injection
WO2020109344A1 (en) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Occular administration device for antisense oligonucleotides
WO2020109343A1 (en) 2018-11-29 2020-06-04 F. Hoffmann-La Roche Ag Combination therapy for treatment of macular degeneration
EP3897714A1 (en) 2018-12-18 2021-10-27 Novartis AG Protein solution formulation containing high concentration of an anti-vegf antibody
CN109498264B (en) * 2018-12-21 2020-01-14 南通市第一人民医院 Silicone oil taking device for ophthalmic surgery
EP3689397A1 (en) * 2019-01-31 2020-08-05 SCHOTT Schweiz AG Syringe body, syringe and injection device for injecting a highly viscous medium
GB201902355D0 (en) * 2019-02-21 2019-04-10 New Injection Systems Ltd Modular auto injector
FR3093004B1 (en) * 2019-02-21 2023-04-07 Dev Techniques Plastiques METHOD FOR PREPARING A SYRINGE
HUE057779T2 (en) * 2019-03-29 2022-06-28 Kortuc Inc Hydrogen peroxide solution-prefilled syringe having excellent hydrogen peroxide preservability by virtue of silicone oil (oil composition containing said silicone oil)
AU2020257540A1 (en) 2019-04-18 2021-11-04 Boehringer Ingelheim International Gmbh Administration device for administration of a fluid
CN113966240B (en) 2019-06-05 2024-08-13 里珍纳龙药品有限公司 Device and method for accurate dose delivery
US12059555B2 (en) * 2019-09-03 2024-08-13 Amgen Inc. Injection device for drug delivery and packaging for the injection device
CN114786731A (en) 2019-10-10 2022-07-22 科达制药股份有限公司 Methods of treating ocular disorders
CN115038480A (en) 2019-11-14 2022-09-09 和谐医疗解决方案有限责任公司 Variable dose syringe
CN115003262A (en) 2019-12-05 2022-09-02 豪夫迈·罗氏有限公司 Syringe and tightness testing method
JP2023506180A (en) * 2019-12-12 2023-02-15 ノバルティス アーゲー Injection device and injection solution transfer system
EP4098298A4 (en) * 2020-03-24 2023-07-19 TERUMO Kabushiki Kaisha Syringe-barrel grip, barrel assembly, and syringe
US11883635B2 (en) 2020-06-17 2024-01-30 Credence MedSystems System and method for microdose injection
CN116583314A (en) 2020-10-30 2023-08-11 勃林格殷格翰国际公司 Feeding device for intravitreal feeding of in particular fluids
CA3201808A1 (en) 2020-12-01 2022-06-09 Boehringer Ingelheim International Gmbh Administration device for in particular intravitreal administration of a fluid
WO2022147408A1 (en) * 2020-12-29 2022-07-07 W. L. Gore & Associates, Inc. Drug injection stopper with thin film lubricant
KR102419910B1 (en) * 2021-04-15 2022-07-14 주식회사 알테오젠 Pre-filled syringe filled with low-volume liquid pharmaceuticals and Manufacturing method thereof
CN114146220B (en) 2022-02-10 2022-04-29 中国远大集团有限责任公司 Cosmetic product containing sterile PCL microspheres
EP4389176A1 (en) 2022-12-20 2024-06-26 W. L. Gore & Associates, Inc. Low insertion force syringe stoppers, assemblies, and associated methods
CN117942456B (en) * 2024-03-27 2024-07-12 山东永聚医药科技股份有限公司 Pre-filled and sealed syringe for slow-release non-Newtonian fluid preparation and preparation process thereof

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31789A (en) 1861-03-26 Bread-slicebi
DE2629557B2 (en) 1976-07-01 1980-05-14 Paul E. Dr.Med. 8000 Muenchen Doerr Disposable injection syringe
JPH0747045B2 (en) * 1986-10-15 1995-05-24 株式会社大協精工 Stacked syringe stopper
US4946441A (en) 1988-07-21 1990-08-07 Maurice Laderoute Limited use hypodermic syringe
JPH0725963Y2 (en) 1989-11-06 1995-06-14 清坤 曽 Emergency evacuation device
US5290228A (en) * 1990-11-17 1994-03-01 Santen Seiyaku Kabushiki Kaisha Two-compartment syringe
US5236604A (en) * 1991-05-29 1993-08-17 Sherwood Medical Company Serum separation blood collection tube and the method of using thereof
JP3186422B2 (en) 1993-05-14 2001-07-11 武田薬品工業株式会社 Plastisol
US5405326A (en) 1993-08-26 1995-04-11 Habley Medical Technology Corporation Disposable safety syringe with retractable shuttle for luer lock needle
US5795337A (en) 1994-02-14 1998-08-18 Becton Dickinson And Company Syringe assembly and syringe stopper
US5688252A (en) 1994-09-30 1997-11-18 Takeda Chemical Industries, Ltd. Syringe
US5667495A (en) 1995-04-21 1997-09-16 Becton Dickinson France S.A. Backstop device for a syringe
US5607400A (en) * 1995-05-19 1997-03-04 Becton, Dickinson And Company Pre-fillable syringe and stopper assembly therefor
DE19622283A1 (en) 1996-05-23 1997-11-27 Schering Ag Process for the terminal sterilization of filled syringes
JP4078406B2 (en) * 1997-01-22 2008-04-23 有限会社コーキ・エンジニアリング Method for manufacturing syringe cylinder
DE122007000021I1 (en) 1997-04-07 2007-05-24 Genentech Inc Anti-vefg Antibodies
JP3387775B2 (en) * 1997-05-22 2003-03-17 株式会社大協精工 Sealing stopper for syringe and prefilled syringe
US6200627B1 (en) * 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
CA2329707A1 (en) * 1998-04-30 1999-11-04 Abbott Laboratories Syringe assembly
USD430015S (en) 1998-06-11 2000-08-29 Pharmacia & Upjohn Ab Blister pack for a syringe
JP2001104480A (en) * 1999-10-05 2001-04-17 Daikyo Seiko Ltd Rubber piston used for sealing plastic prefilled syringe
JP2001340455A (en) 2000-05-31 2001-12-11 Yoshino Kogyosho Co Ltd Syringe container
JP2002177388A (en) 2000-12-15 2002-06-25 Daikyo Seiko Ltd Pharmaceutical and medical pre-filled syringe
JP2002241264A (en) * 2001-02-19 2002-08-28 Asahi Kasei Corp Prefilled syringe pharmaceutical preparation of elcatonin
US20050154354A1 (en) * 2001-12-27 2005-07-14 Yoshihiko Kawasaki Cartridge syringe, cartridge and ophthalmologic syringe set having such syringe
JP4141156B2 (en) 2002-03-15 2008-08-27 日本ベクトン・ディッキンソン株式会社 Prefilled syringe with plunger retraction limit mechanism
US6688252B1 (en) 2002-12-11 2004-02-10 Gary Caravella Boat cover
EP1596909A2 (en) 2003-02-27 2005-11-23 Baxter International Inc. Piston assembly for syringe
JP2004313369A (en) 2003-04-15 2004-11-11 Menicon Co Ltd Cartridge injector, cartridge and ophthalmological injector set with the injector
FR2855413B1 (en) 2003-05-26 2005-12-30 Becton Dickinson France PRE-FILLED SYRINGE WITH ANTI-EFFRACTION COIFFE
BRPI0506837A (en) * 2004-01-12 2007-06-12 Iscience Surgical Corp viscous material injector, and devices and kit for providing micro-quantities of viscous materials
US8124207B2 (en) 2004-03-02 2012-02-28 Sakhrani Vinay G Article with lubricated surface and method
WO2005121176A1 (en) 2004-06-08 2005-12-22 Chengdu Kanghong Biotechnologies Co. Ltd Angiogenesis-inhibiting chimeric protein and the use
NZ598502A (en) * 2004-10-21 2013-07-26 Genentech Inc Use of vegf antagonists in intraocular neovascular disease treatment
EP1877438A2 (en) * 2005-02-02 2008-01-16 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a vegf inhibitor
WO2006128564A1 (en) 2005-05-31 2006-12-07 Baxter International Inc. Polypropylene hollow barrel with sliding coated rubber piston
US20060293270A1 (en) * 2005-06-22 2006-12-28 Adamis Anthony P Methods and compositions for treating ocular disorders
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
FR2890316B1 (en) * 2005-09-02 2007-10-05 Aguettant Soc Par Actions Simp SYRINGE FOR FILLING THEN STERILIZED BY STEAM AUTOCLAVING.
JP2009508593A (en) * 2005-09-16 2009-03-05 （オーエスアイ）アイテツク・インコーポレーテツド Ophthalmic syringe
US20070083770A1 (en) 2005-09-17 2007-04-12 Technology Group Northwest Inc. System and method for foiling code-injection attacks in a computing device
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
CN101365456A (en) * 2005-10-14 2009-02-11 爱尔康公司 Method for treating primary and secondary forms of glaucoma
AT502791B1 (en) * 2006-04-06 2007-05-15 Pharma Consult Ges M B H & Co Injection syringe, has plastic needle holder enclosing stainless steel injection needle, where holder receives injection solution in relation to interior of cylinder and is sealed off by sealing insert, by which rear end of needle protrudes
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
CA2651194A1 (en) * 2006-05-04 2007-11-15 Fondation Ophthalmologique Aldolphe De Rothschild Methods for treating neovascular diseases
EP2364691B1 (en) 2006-06-16 2013-04-24 Regeneron Pharmaceuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration
JP4131001B2 (en) 2006-07-28 2008-08-13 大成化工株式会社 Metering device
CN200973886Y (en) * 2006-11-20 2007-11-14 骆忠林 Syringe
WO2008077155A1 (en) 2006-12-21 2008-06-26 Genentech, Inc. Sterilization of objects containing biological molecules
US8529521B2 (en) 2007-04-23 2013-09-10 Ultimed Inc. Low-dosage syringe
CN100563736C (en) * 2007-06-02 2009-12-02 丁锐 Disposable anti-stabbed syringe
JP5409615B2 (en) 2007-06-12 2014-02-05 ベクトン・ディキンソン・アンド・カンパニー Syringe with disabling mechanism
PL2020245T3 (en) * 2007-07-31 2012-04-30 Al Chi Mi A S R L Method for making a device for ophthalmic treatments
WO2009030975A1 (en) 2007-09-03 2009-03-12 Becton Dickinson France Medical device comprising a siliconized chamber and a coated closure means
WO2009030976A1 (en) 2007-09-03 2009-03-12 Becton Dickinson France Medical device and smooth coating therefor
WO2009092608A1 (en) 2008-01-24 2009-07-30 Meflex Telecontrol Gmbh & Co. Kg Terminus cap for a drive cable, drive cable, method for the production of a terminus cap, and method for the production of a drive cable
DE102008005938A1 (en) * 2008-01-24 2009-07-30 Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg Pre-filled syringe for use in ophthalmology field, has piston rod with end coupled with stopper and opposite end, and aseptic secondary package e.g. cylindrical casing, with inner area provided for accommodation of syringe
JP2011519347A (en) 2008-02-07 2011-07-07 アムジエン・インコーポレーテツド Stabilized protein composition
CN102065939B (en) * 2008-06-17 2013-06-19 电气化学工业株式会社 Injector
WO2009158613A1 (en) 2008-06-26 2009-12-30 West Pharmaceutical Services, Inc. Method of coating polyxylylene onto flouropolymer surfaces and devices coated thereby
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
US20110276005A1 (en) * 2008-12-03 2011-11-10 Taisei Kako Co., Ltd. Syringe
EP3165606A1 (en) * 2009-05-01 2017-05-10 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
BRPI1013807A2 (en) * 2009-05-28 2019-09-24 Glaxo Group Ltd composition, use of a composition, antagonist, polynucleotide sequence, transformed or transfected recombinant host cell, method for producing a composition, method for preventing or treating a patient, dual-labeling antigen binding molecule, and binding protein of antigen.
EP2266647A1 (en) * 2009-06-25 2010-12-29 Sanofi-Aventis Deutschland GmbH Drive mechanism for drug delivery device
AR078060A1 (en) 2009-07-14 2011-10-12 Novartis Ag DECONTAMINATION OF CONTAINER SURFACE PREVIOUSLY FILLED IN SECONDARY PACKAGING
CN102725012B (en) 2009-10-29 2016-01-06 W.L.戈尔及同仁股份有限公司 The syringe plug of coating intumescent PTFE
CN201578690U (en) 2010-01-21 2010-09-15 王建友 Syringe
CA2795096C (en) 2010-03-31 2021-10-26 Ocuject, Llc Device and method for intraocular drug delivery
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
AR081361A1 (en) 2010-04-30 2012-08-29 Molecular Partners Ag MODIFIED UNION PROTEINS THAT INHIBIT THE RECEPTOR INTERACTION OF THE VASCULAR ENDOTELIAL GROWTH FACTOR FROM GLICOPROTEIN TO VEGF-A
JP2012045046A (en) 2010-08-24 2012-03-08 Gc Corp Dental syringe
FR2966044B1 (en) 2010-10-18 2012-11-02 Sanofi Pasteur METHOD FOR CONDITIONING A VACCINE CONTAINING AN ALUMINUM ADJUVANT
WO2012117837A1 (en) 2011-03-01 2012-09-07 テルモ株式会社 Syringe and syringe assembly
RS58825B1 (en) 2011-04-25 2019-07-31 Icon Bioscience Inc Dose guides for injection syringe
US20130012918A1 (en) 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method
RU2621843C2 (en) 2011-09-27 2017-06-07 Бектон Дикинсон Франс Application of plasma-treated silicone oil as coatings in medical injection device
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
HRP20211572T1 (en) 2012-06-01 2022-02-04 Novartis Ag Syringe
DE202012011016U1 (en) 2012-07-03 2012-11-28 Novartis Ag Aflibercept syringe
AU2013100071C4 (en) 2012-07-03 2013-05-02 Novartis Ag Device
JOP20200175A1 (en) 2012-07-03 2017-06-16 Novartis Ag Syringe
US9662450B2 (en) * 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus

Also Published As

Publication number Publication date
CA2803566A1 (en) 2014-01-03
CN104427972A (en) 2015-03-18
CN110115657A (en) 2019-08-13
EP3685826A1 (en) 2020-07-29
IL272915B (en) 2021-02-28
FR2983077A1 (en) 2013-05-31
PL2869813T3 (en) 2019-05-31
ES2882254T3 (en) 2021-12-01
DE202013000688U1 (en) 2013-03-05
KR20150030216A (en) 2015-03-19
SI3381444T1 (en) 2021-09-30
CL2014003619A1 (en) 2015-10-02
PH12014502785B1 (en) 2015-02-02
US9220631B2 (en) 2015-12-29
LT3685826T (en) 2022-02-10
PH12014502785A1 (en) 2015-02-02
CH706741B1 (en) 2014-02-14
MX358323B (en) 2018-08-14
JP2014087678A (en) 2014-05-15
HRP20220083T1 (en) 2022-04-15
MX2014015743A (en) 2015-07-23
US20140012227A1 (en) 2014-01-09
JP5744927B2 (en) 2015-07-08
JO3655B1 (en) 2020-08-27
KR102092427B1 (en) 2020-04-17
CH706741A2 (en) 2014-01-15
CN111249062A (en) 2020-06-09
PE20150196A1 (en) 2015-03-02
HRP20211216T1 (en) 2021-10-29
AU2013201624A1 (en) 2014-01-23
MA37740B2 (en) 2020-10-28
EA031583B1 (en) 2019-01-31
KR102299177B1 (en) 2021-09-08
BR112014032990B1 (en) 2022-01-04
ES2912848T3 (en) 2022-05-30
KR20220062681A (en) 2022-05-17
BR112014032990A2 (en) 2018-03-06
KR102443606B1 (en) 2022-09-14
EP3656373B1 (en) 2022-02-16
EP3470058A1 (en) 2019-04-17
BR122020020290B1 (en) 2022-04-05
SI3685826T1 (en) 2022-02-28
KR102487296B1 (en) 2023-01-13
KR20210113413A (en) 2021-09-15
PL3685826T3 (en) 2022-03-21
EP2869813B1 (en) 2018-11-21
JP2014028114A (en) 2014-02-13
PT2869813T (en) 2019-02-27
ECSP15004005A (en) 2018-10-31
TW201402152A (en) 2014-01-16
DK3685826T3 (en) 2022-02-14
KR20210156865A (en) 2021-12-27
IL236296A0 (en) 2015-02-26
HUE042652T2 (en) 2019-07-29
TN2014000517A1 (en) 2016-03-30
DK3381444T3 (en) 2021-08-09
TWI632920B (en) 2018-08-21
KR20220130821A (en) 2022-09-27
PL3381444T3 (en) 2021-11-22
EP3685826B1 (en) 2021-11-03
CY1121497T1 (en) 2020-05-29
SI3656373T1 (en) 2022-06-30
IL236296B (en) 2020-04-30
NZ702980A (en) 2017-06-30
SG11201408261UA (en) 2015-01-29
HUE055227T2 (en) 2021-11-29
LT3656373T (en) 2022-05-10
IL272915A (en) 2020-04-30
DK2869813T3 (en) 2019-03-18
EP2869813A1 (en) 2015-05-13
HRP20220535T1 (en) 2022-07-08
DK3656373T3 (en) 2022-05-16
ES2712152T3 (en) 2019-05-09
SI2869813T1 (en) 2019-04-30
LT2869813T (en) 2019-03-12
ZA201409411B (en) 2015-11-25
ES2906812T3 (en) 2022-04-20
MA37740A1 (en) 2016-11-30
KR20230013282A (en) 2023-01-26
EP3381444B1 (en) 2021-05-19
HK1188404A1 (en) 2014-05-02
WO2014005728A1 (en) 2014-01-09
CO7151483A2 (en) 2014-12-29
KR102395557B1 (en) 2022-05-09
KR102341670B1 (en) 2021-12-22
KR20200029611A (en) 2020-03-18
EP3381444A1 (en) 2018-10-03
CN112972828A (en) 2021-06-18
MY164536A (en) 2017-12-29
JOP20200175A1 (en) 2017-06-16
CY1124431T1 (en) 2022-07-22
LT3381444T (en) 2021-08-25
EP3656373A1 (en) 2020-05-27
JP6313038B2 (en) 2018-04-18
HUE057746T2 (en) 2022-06-28
EA201590139A1 (en) 2015-07-30
GT201400300A (en) 2015-10-15
PL3656373T3 (en) 2022-06-20
HRP20190300T1 (en) 2019-04-05
AR090059A1 (en) 2014-10-15

Similar Documents

Publication Publication Date Title
FR2983077B1 (en) SYRINGE
EA201590173A1 (en) IMMUNOCONGUTS CONTAINING ANTIBODIES TO CD22
GT201400279A (en) SYRINGE
MA33936B1 (en) Antidote to anticoagulants
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
PH12014502406B1 (en) Anti-il-23p19 antibodies
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
FR2975600B1 (en) AGENTS FOR THE TREATMENT OF TUMORS
FR2995713B1 (en) DISPLAY SCREEN, ESPECIALLY FOR AUTOSTEREOSCOPY.
TR201821285T4 (en) Pharmaceutical formulations containing a CCR3 antagonist.
MA42166B1 (en) Syringe
CL2013000069A1 (en) Compounds derived from fused heterocycles, s1p modulators; pharmaceutical composition; and use in neurodegenerative diseases.
MA34978B1 (en) ANTIDOTES FOR ANTICOAGULANTS
EA201590651A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING REBAMIPID
WO2014044793A3 (en) Cd22-binding peptides
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
EA201301355A1 (en) COMPOSITION AND TABLET CONTAINING RALTEGRAVIR
CY1124956T1 (en) SYRINGE
IN2015KN00386A (en)
UA105703C2 (en) 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents
TN2014000207A1 (en) Anti il-36r antibodies
UA78284U (en) 5,11- dibenzyl -8-thioxo-13-(2-chlorophenyl)-3,5,7,11- tetraazatricyclo[7.3.1.02,7]tridec-2-ene-1,9-dicarbonitrile

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

RT Complete renunciation

Effective date: 20221121